Compare RCUS & PVH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RCUS | PVH |
|---|---|---|
| Founded | 2015 | 1881 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 3.2B |
| IPO Year | 2018 | 1994 |
| Metric | RCUS | PVH |
|---|---|---|
| Price | $20.29 | $66.43 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 16 |
| Target Price | $29.20 | ★ $89.27 |
| AVG Volume (30 Days) | ★ 1.1M | 808.9K |
| Earning Date | 05-05-2026 | 03-31-2026 |
| Dividend Yield | N/A | ★ 0.23% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 3.72 |
| Revenue | $247,000,000.00 | ★ $8,652,900,000.00 |
| Revenue This Year | N/A | $3.66 |
| Revenue Next Year | $70.88 | $1.79 |
| P/E Ratio | ★ N/A | $17.88 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.79 | $59.28 |
| 52 Week High | $26.40 | $89.79 |
| Indicator | RCUS | PVH |
|---|---|---|
| Relative Strength Index (RSI) | 43.14 | 53.42 |
| Support Level | $18.52 | $60.58 |
| Resistance Level | $21.55 | $71.32 |
| Average True Range (ATR) | 1.08 | 2.08 |
| MACD | -0.27 | 0.49 |
| Stochastic Oscillator | 3.95 | 71.50 |
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
PVH designs and markets branded apparel in more than 40 countries. Its key fashion categories include men's dress shirts, ties, sportswear, underwear, and jeans. Its two designer brands, Calvin Klein and Tommy Hilfiger, now generate practically all its revenue after its recent disposition of most of its smaller brands. PVH operates e-commerce sites, about 1,400 stores, and about 1,500 shop-in-shops and concessions. The firm also licenses its brands to third parties and distributes its merchandise through department stores and other wholesale accounts. PVH traces its history to 1881 and is based in New York City.